Covid-19 Impact on Cancer Tumor Profiling Market, Global Research Reports 2020-2021

June 2020 | 103 pages | ID: CECC994B68BEEN
QYResearch

Abstracts

This report covers market size and forecasts of Cancer Tumor Profiling, including the following market information:

• Global Cancer Tumor Profiling Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
• Global Cancer Tumor Profiling Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
• Global Cancer Tumor Profiling Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
• Global Cancer Tumor Profiling Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)

Key market players

Major competitors identified in this market include Qiagen N.V., Roche Molecular Systems Inc., Abott Molecular, Illumina Inc., NeoGenomics Laboratories, HTG Molecular Diagnostic, Genomic Health Inc., Hologic Gen-Probe, BD Biosciences, Siemens Healthineers, Claris Life Sciences, Personal Genome Diagnostics, Inc., Perthera, Inc., Foundation Medicine, Inc, V., Strand, ApoCell, Contextual Genomics, Agendia, GenScript, etc.

Based on the Region:

• Asia-Pacific (China, Japan, South Korea, India and ASEAN)
• North America (US and Canada)
• Europe (Germany, France, UK and Italy)
• Rest of World (Latin America, Middle East & Africa)

Based on the Type:

• Next-generation Sequencing (NGS)
• Polymerase Chain Reaction (PCR)
• Immunohistochemistry (IHC)
• In Situ Hybridization (ISH)
• Microarray
• Others

Based on the Application:

• Personalized Medicine
• Diagnostics
• Biomarker Discovery
• Prognostics
• Research Applications

Contents

1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
  1.4.1 Research Process
  1.4.2 Data Triangulation
  1.4.3 Research Approach
  1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
  1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
  1.5.2 Covid-19 Impact: Commodity Prices Indices
  1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Cancer Tumor Profiling Industry
1.7 COVID-19 Impact: Cancer Tumor Profiling Market Trends

2 GLOBAL CANCER TUMOR PROFILING QUARTERLY MARKET SIZE ANALYSIS

2.1 Cancer Tumor Profiling Business Impact Assessment - COVID-19
  2.1.1 Global Cancer Tumor Profiling Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Cancer Tumor Profiling Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
  2.3.1 Drivers
  2.3.2 Restraints
  2.3.3 Opportunities
  2.3.4 Challenges

3 QUARTERLY COMPETITIVE ASSESSMENT, 2020

3.1 By Players, Global Cancer Tumor Profiling Quarterly Market Size, 2019 VS 2020
3.2 By Players, Cancer Tumor Profiling Headquarters and Area Served
3.3 Date of Key Players Enter into Cancer Tumor Profiling Market
3.4 Key Players Cancer Tumor Profiling Product Offered
3.5 Mergers & Acquisitions, Expansion Plans

4 IMPACT OF COVID-19 ON CANCER TUMOR PROFILING SEGMENTS, BY TYPE

4.1 Introduction
  1.4.1 Next-generation Sequencing (NGS)
  1.4.2 Polymerase Chain Reaction (PCR)
  1.4.3 Immunohistochemistry (IHC)
  1.4.4 In Situ Hybridization (ISH)
  1.4.5 Microarray
  1.4.6 Others
4.2 By Type, Global Cancer Tumor Profiling Market Size, 2019-2021

5 IMPACT OF COVID-19 ON CANCER TUMOR PROFILING SEGMENTS, BY APPLICATION

5.1 Overview
  5.5.1 Personalized Medicine
  5.5.2 Diagnostics
  5.5.3 Biomarker Discovery
  5.5.4 Prognostics
  5.5.5 Research Applications
5.2 By Application, Global Cancer Tumor Profiling Market Size, 2019-2021
  5.2.1 By Application, Global Cancer Tumor Profiling Market Size by Application, 2019-2021

6 GEOGRAPHIC ANALYSIS

6.1 Introduction
6.2 North America
  6.2.1 Macroeconomic Indicators of US
  6.2.2 US
  6.2.3 Canada
6.3 Europe
  6.3.1 Macroeconomic Indicators of Europe
  6.3.2 Germany
  6.3.3 France
  6.3.4 UK
  6.3.5 Italy
6.4 Asia-Pacific
  6.4.1 Macroeconomic Indicators of Asia-Pacific
  6.4.2 China
  6.4.3 Japan
  6.4.4 South Korea
  6.4.5 India
  6.4.6 ASEAN
6.5 Rest of World
  6.5.1 Latin America
  6.5.2 Middle East and Africa

7 COMPANY PROFILES

7.1 Qiagen N.V.
  7.1.1 Qiagen N.V. Business Overview
  7.1.2 Qiagen N.V. Cancer Tumor Profiling Quarterly Revenue, 2020
  7.1.3 Qiagen N.V. Cancer Tumor Profiling Product Introduction
  7.1.4 Qiagen N.V. Response to COVID-19 and Related Developments
7.2 Roche Molecular Systems Inc.
  7.2.1 Roche Molecular Systems Inc. Business Overview
  7.2.2 Roche Molecular Systems Inc. Cancer Tumor Profiling Quarterly Revenue, 2020
  7.2.3 Roche Molecular Systems Inc. Cancer Tumor Profiling Product Introduction
  7.2.4 Roche Molecular Systems Inc. Response to COVID-19 and Related Developments
7.3 Abott Molecular
  7.3.1 Abott Molecular Business Overview
  7.3.2 Abott Molecular Cancer Tumor Profiling Quarterly Revenue, 2020
  7.3.3 Abott Molecular Cancer Tumor Profiling Product Introduction
  7.3.4 Abott Molecular Response to COVID-19 and Related Developments
7.4 Illumina Inc.
  7.4.1 Illumina Inc. Business Overview
  7.4.2 Illumina Inc. Cancer Tumor Profiling Quarterly Revenue, 2020
  7.4.3 Illumina Inc. Cancer Tumor Profiling Product Introduction
  7.4.4 Illumina Inc. Response to COVID-19 and Related Developments
7.5 NeoGenomics Laboratories
  7.5.1 NeoGenomics Laboratories Business Overview
  7.5.2 NeoGenomics Laboratories Cancer Tumor Profiling Quarterly Revenue, 2020
  7.5.3 NeoGenomics Laboratories Cancer Tumor Profiling Product Introduction
  7.5.4 NeoGenomics Laboratories Response to COVID-19 and Related Developments
7.6 HTG Molecular Diagnostic
  7.6.1 HTG Molecular Diagnostic Business Overview
  7.6.2 HTG Molecular Diagnostic Cancer Tumor Profiling Quarterly Revenue, 2020
  7.6.3 HTG Molecular Diagnostic Cancer Tumor Profiling Product Introduction
  7.6.4 HTG Molecular Diagnostic Response to COVID-19 and Related Developments
7.7 Genomic Health Inc.
  7.7.1 Genomic Health Inc. Business Overview
  7.7.2 Genomic Health Inc. Cancer Tumor Profiling Quarterly Revenue, 2020
  7.7.3 Genomic Health Inc. Cancer Tumor Profiling Product Introduction
  7.7.4 Genomic Health Inc. Response to COVID-19 and Related Developments
7.8 Hologic Gen-Probe
  7.8.1 Hologic Gen-Probe Business Overview
  7.8.2 Hologic Gen-Probe Cancer Tumor Profiling Quarterly Revenue, 2020
  7.8.3 Hologic Gen-Probe Cancer Tumor Profiling Product Introduction
  7.8.4 Hologic Gen-Probe Response to COVID-19 and Related Developments
7.9 BD Biosciences
  7.9.1 BD Biosciences Business Overview
  7.9.2 BD Biosciences Cancer Tumor Profiling Quarterly Revenue, 2020
  7.9.3 BD Biosciences Cancer Tumor Profiling Product Introduction
  7.9.4 BD Biosciences Response to COVID-19 and Related Developments
7.10 Siemens Healthineers
  7.10.1 Siemens Healthineers Business Overview
  7.10.2 Siemens Healthineers Cancer Tumor Profiling Quarterly Revenue, 2020
  7.10.3 Siemens Healthineers Cancer Tumor Profiling Product Introduction
  7.10.4 Siemens Healthineers Response to COVID-19 and Related Developments
7.11 Claris Life Sciences
  7.11.1 Claris Life Sciences Business Overview
  7.11.2 Claris Life Sciences Cancer Tumor Profiling Quarterly Revenue, 2020
  7.11.3 Claris Life Sciences Cancer Tumor Profiling Product Introduction
  7.11.4 Claris Life Sciences Response to COVID-19 and Related Developments
7.12 Personal Genome Diagnostics, Inc.
  7.12.1 Personal Genome Diagnostics, Inc. Business Overview
  7.12.2 Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Quarterly Revenue, 2020
  7.12.3 Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Product Introduction
  7.12.4 Personal Genome Diagnostics, Inc. Response to COVID-19 and Related Developments
7.13 Perthera, Inc.
  7.13.1 Perthera, Inc. Business Overview
  7.13.2 Perthera, Inc. Cancer Tumor Profiling Quarterly Revenue, 2020
  7.13.3 Perthera, Inc. Cancer Tumor Profiling Product Introduction
  7.13.4 Perthera, Inc. Response to COVID-19 and Related Developments
7.14 Foundation Medicine, Inc
  7.14.1 Foundation Medicine, Inc Business Overview
  7.14.2 Foundation Medicine, Inc Cancer Tumor Profiling Quarterly Revenue, 2020
  7.14.3 Foundation Medicine, Inc Cancer Tumor Profiling Product Introduction
  7.14.4 Foundation Medicine, Inc Response to COVID-19 and Related Developments
7.15 V., Strand
  7.15.1 V., Strand Business Overview
  7.15.2 V., Strand Cancer Tumor Profiling Quarterly Revenue, 2020
  7.15.3 V., Strand Cancer Tumor Profiling Product Introduction
  7.15.4 V., Strand Response to COVID-19 and Related Developments
7.16 ApoCell
  7.16.1 ApoCell Business Overview
  7.16.2 ApoCell Cancer Tumor Profiling Quarterly Revenue, 2020
  7.16.3 ApoCell Cancer Tumor Profiling Product Introduction
  7.16.4 ApoCell Response to COVID-19 and Related Developments
7.17 Contextual Genomics
  7.17.1 Contextual Genomics Business Overview
  7.17.2 Contextual Genomics Cancer Tumor Profiling Quarterly Revenue, 2020
  7.17.3 Contextual Genomics Cancer Tumor Profiling Product Introduction
  7.17.4 Contextual Genomics Response to COVID-19 and Related Developments
7.18 Agendia
  7.18.1 Agendia Business Overview
  7.18.2 Agendia Cancer Tumor Profiling Quarterly Revenue, 2020
  7.18.3 Agendia Cancer Tumor Profiling Product Introduction
  7.18.4 Agendia Response to COVID-19 and Related Developments
7.19 GenScript
  7.19.1 GenScript Business Overview
  7.19.2 GenScript Cancer Tumor Profiling Quarterly Revenue, 2020
  7.19.3 GenScript Cancer Tumor Profiling Product Introduction
  7.19.4 GenScript Response to COVID-19 and Related Developments

8 KEY FINDINGS

9 APPENDIX

9.1 About US
9.2 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Cancer Tumor Profiling Assessment
Table 9. COVID-19 Impact: Cancer Tumor Profiling Market Trends
Table 10. COVID-19 Impact Global Cancer Tumor Profiling Market Size
Table 11. Global Cancer Tumor Profiling Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Cancer Tumor Profiling Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Cancer Tumor Profiling Market Growth Drivers
Table 14. Global Cancer Tumor Profiling Market Restraints
Table 15. Global Cancer Tumor Profiling Market Opportunities
Table 16. Global Cancer Tumor Profiling Market Challenges
Table 17. By Players, Cancer Tumor Profiling Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Cancer Tumor Profiling Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Cancer Tumor Profiling Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Cancer Tumor Profiling Market
Table 21. Key Players Cancer Tumor Profiling Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Cancer Tumor Profiling Market Size 2019-2021, (US$ Million)
Table 24. Global Cancer Tumor Profiling Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Cancer Tumor Profiling Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Cancer Tumor Profiling Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Cancer Tumor Profiling Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Cancer Tumor Profiling Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Cancer Tumor Profiling Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Cancer Tumor Profiling Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Cancer Tumor Profiling Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Cancer Tumor Profiling Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Cancer Tumor Profiling Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Cancer Tumor Profiling Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Cancer Tumor Profiling Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Cancer Tumor Profiling Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Cancer Tumor Profiling Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Cancer Tumor Profiling Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Cancer Tumor Profiling Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Cancer Tumor Profiling Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Cancer Tumor Profiling Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Cancer Tumor Profiling Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Cancer Tumor Profiling Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Cancer Tumor Profiling Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Cancer Tumor Profiling Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Cancer Tumor Profiling Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Cancer Tumor Profiling Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Cancer Tumor Profiling Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Cancer Tumor Profiling Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Cancer Tumor Profiling Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Cancer Tumor Profiling Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Cancer Tumor Profiling Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Cancer Tumor Profiling Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Cancer Tumor Profiling Market Size, 2019-2021 (US$ Million)
Table 57. Qiagen N.V. Business Overview
Table 58. Qiagen N.V. Cancer Tumor Profiling Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Qiagen N.V. Cancer Tumor Profiling Product
Table 60. Qiagen N.V. Response to COVID-19 and Related Developments
Table 61. Roche Molecular Systems Inc. Business Overview
Table 62. Roche Molecular Systems Inc. Cancer Tumor Profiling Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Roche Molecular Systems Inc. Cancer Tumor Profiling Product
Table 64. Roche Molecular Systems Inc. Response to COVID-19 and Related Developments
Table 65. Abott Molecular Business Overview
Table 66. Abott Molecular Cancer Tumor Profiling Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Abott Molecular Cancer Tumor Profiling Product
Table 68. Abott Molecular Response to COVID-19 and Related Developments
Table 69. Illumina Inc. Business Overview
Table 70. Illumina Inc. Cancer Tumor Profiling Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Illumina Inc. Cancer Tumor Profiling Product
Table 72. Illumina Inc. Response to COVID-19 and Related Developments
Table 73. NeoGenomics Laboratories Business Overview
Table 74. NeoGenomics Laboratories Cancer Tumor Profiling Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. NeoGenomics Laboratories Cancer Tumor Profiling Product
Table 76. NeoGenomics Laboratories Response to COVID-19 and Related Developments
Table 77. HTG Molecular Diagnostic Business Overview
Table 78. HTG Molecular Diagnostic Cancer Tumor Profiling Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. HTG Molecular Diagnostic Cancer Tumor Profiling Product
Table 80. HTG Molecular Diagnostic Response to COVID-19 and Related Developments
Table 81. Genomic Health Inc. Business Overview
Table 82. Genomic Health Inc. Cancer Tumor Profiling Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Genomic Health Inc. Cancer Tumor Profiling Product
Table 84. Genomic Health Inc. Response to COVID-19 and Related Developments
Table 85. Hologic Gen-Probe Business Overview
Table 86. Hologic Gen-Probe Cancer Tumor Profiling Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Hologic Gen-Probe Cancer Tumor Profiling Product
Table 88. Hologic Gen-Probe Response to COVID-19 and Related Developments
Table 89. BD Biosciences Business Overview
Table 90. BD Biosciences Cancer Tumor Profiling Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. BD Biosciences Cancer Tumor Profiling Product
Table 92. BD Biosciences Response to COVID-19 and Related Developments
Table 93. Siemens Healthineers Business Overview
Table 94. Siemens Healthineers Cancer Tumor Profiling Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Siemens Healthineers Cancer Tumor Profiling Product
Table 96. Siemens Healthineers Response to COVID-19 and Related Developments
Table 97. Claris Life Sciences Business Overview
Table 98. Claris Life Sciences Cancer Tumor Profiling Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. Claris Life Sciences Cancer Tumor Profiling Product
Table 100. Claris Life Sciences Response to COVID-19 and Related Developments
Table 101. Personal Genome Diagnostics, Inc. Business Overview
Table 102. Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 103. Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Product
Table 104. Personal Genome Diagnostics, Inc. Response to COVID-19 and Related Developments
Table 105. Perthera, Inc. Business Overview
Table 106. Perthera, Inc. Cancer Tumor Profiling Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 107. Perthera, Inc. Cancer Tumor Profiling Product
Table 108. Perthera, Inc. Response to COVID-19 and Related Developments
Table 109. Foundation Medicine, Inc Business Overview
Table 110. Foundation Medicine, Inc Cancer Tumor Profiling Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 111. Foundation Medicine, Inc Cancer Tumor Profiling Product
Table 112. Foundation Medicine, Inc Response to COVID-19 and Related Developments
Table 113. V., Strand Business Overview
Table 114. V., Strand Cancer Tumor Profiling Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 115. V., Strand Cancer Tumor Profiling Product
Table 116. V., Strand Response to COVID-19 and Related Developments
Table 117. ApoCell Business Overview
Table 118. ApoCell Cancer Tumor Profiling Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 119. ApoCell Cancer Tumor Profiling Product
Table 120. ApoCell Response to COVID-19 and Related Developments
Table 121. Contextual Genomics Business Overview
Table 122. Contextual Genomics Cancer Tumor Profiling Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 123. Contextual Genomics Cancer Tumor Profiling Product
Table 124. Contextual Genomics Response to COVID-19 and Related Developments
Table 125. Agendia Business Overview
Table 126. Agendia Cancer Tumor Profiling Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 127. Agendia Cancer Tumor Profiling Product
Table 128. Agendia Response to COVID-19 and Related Developments
Table 129. GenScript Business Overview
Table 130. GenScript Cancer Tumor Profiling Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 131. GenScript Cancer Tumor Profiling Product
Table 132. GenScript Response to COVID-19 and Related Developments

List Of Figures

LIST OF FIGURES

Figure 1. Cancer Tumor Profiling Product Picture
Figure 2. Cancer Tumor Profiling Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Cancer Tumor Profiling Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Cancer Tumor Profiling Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Cancer Tumor Profiling Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Cancer Tumor Profiling Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Cancer Tumor Profiling Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Cancer Tumor Profiling Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Cancer Tumor Profiling Market Size Market Share, 2019-2021